Home › Sjogren's Syndrome › Washington
Sjogren's Syndrome clinical trials in Washington, DC
5 studies for Sjogren's Syndrome are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi away
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
The Pathogenesis and Natural History of Sjogren's Disease
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Characterization of Diseases With Salivary Gland Involvement
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
The Myelin Disorders Biorepository Project
RecruitingObservational study
- Children's National Medical Center, Washington D.C.
About Sjogren's Syndrome
Sjogren's Syndrome is an autoimmune disease that causes dryness of the mouth, eyes and other parts of the body. Learn how to relieve the symptoms.
More about Sjogren's Syndrome on MedlinePlus
Sjogren's Syndrome trials in other cities
- Houston, TX6 studies
- Boston, MA5 studies
- Charlotte, NC4 studies
- Tampa, FL4 studies
- Arlington, TX4 studies
- Cicero, IL4 studies
- Tucson, AZ3 studies
- Cypress, TX3 studies
- Kansas City, MO3 studies
- Warren, MI3 studies
- Clearwater, FL3 studies
- Orlando, FL3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.